Works matching AU Muroi, Nobuyuki
Results: 26
Efficiently Reducing Medical Costs through Drug Vial Optimization and Multidose Vials for the Utilization of Cancer Drug Compounding Robots: Efficiently Reducing Medical Costs through Cancer Drug Compounding Robots: E. Usami et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 75, doi. 10.1007/s40267-025-01140-w
- By:
- Publication type:
- Article
Regulation of Histamine Turnover via Muscarinic and Nicotinic Receptors in the Brain.
- Published in:
- Journal of Neurochemistry, 1990, v. 55, n. 6, p. 1899, doi. 10.1111/j.1471-4159.1990.tb05774.x
- By:
- Publication type:
- Article
Correction: Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00389-z
- By:
- Publication type:
- Article
Evaluating the safety and efficiency of robotic dispensing systems.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00255-w
- By:
- Publication type:
- Article
Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390
- By:
- Publication type:
- Article
Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.
- Published in:
- Oncology, 2022, v. 100, n. 7, p. 413, doi. 10.1159/000524806
- By:
- Publication type:
- Article
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 880, doi. 10.1111/cts.12827
- By:
- Publication type:
- Article
Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 396, doi. 10.21873/invivo.13841
- By:
- Publication type:
- Article
Factors Associated With Mortality in Patients With Catheter-related Bloodstream Infection: A Multicenter Retrospective Study.
- Published in:
- In Vivo, 2024, v. 38, n. 6, p. 3041, doi. 10.21873/invivo.13788
- By:
- Publication type:
- Article
Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 1, p. 190, doi. 10.1111/jcpt.13279
- By:
- Publication type:
- Article
Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1288, doi. 10.1111/jcpt.13207
- By:
- Publication type:
- Article
Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00196-w
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 513, doi. 10.1002/psp4.12936
- By:
- Publication type:
- Article
Population pharmacokinetics of favipiravir in patients with COVID‐19.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1161, doi. 10.1002/psp4.12685
- By:
- Publication type:
- Article
Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 298, doi. 10.1111/jcpt.13065
- By:
- Publication type:
- Article
Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.529654
- By:
- Publication type:
- Article
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 3, p. 2341, doi. 10.1007/s00520-021-06634-7
- By:
- Publication type:
- Article
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4763, doi. 10.1007/s00520-021-06018-x
- By:
- Publication type:
- Article
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.901099
- By:
- Publication type:
- Article
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 5, p. 761, doi. 10.1007/s10637-023-01392-1
- By:
- Publication type:
- Article
Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 833, doi. 10.1007/s00280-022-04408-4
- By:
- Publication type:
- Article
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 659, doi. 10.1007/s40801-022-00324-4
- By:
- Publication type:
- Article
Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 9, p. 1355, doi. 10.3390/life12091355
- By:
- Publication type:
- Article